Status:
RECRUITING
Predictive Role of sTREM in Endovascular Thrombectomy Outcomes
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Soluble triggering receptor expressed on myeloid cells (sTREM), which reflects microglia activation, has been reported closely associated with neuronal injury and neuroinflammation. This study is to i...
Detailed Description
For acute ischemic stroke, the current treatment strategy involves timely recanalization by intravenous thrombolysis and endovascular thrombectomy (EVT). Patients receiving EVT are more likely to achi...
Eligibility Criteria
Inclusion
- Patients \> 18 years old.
- Patients with acute large vessel occlusion within 24 hours of onset who will receive endovascular treatment.
Exclusion
- Impossibility of getting a blood sample.
- Impossibility of performing the test (Invalid results).
- Refusal to provide the informed consent by the patient/relative.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06545591
Start Date
July 1 2024
End Date
December 31 2027
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology
Xuzhou, Jiangsu, China